Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 12, 2016 - Issue 3
Submit an article Journal homepage
1,742
Views
30
CrossRef citations to date
0
Altmetric
Research Papers

Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine

Vesna BlazevicVaccine Research Center, University of Tampere Medical School, Tampere, FinlandCorrespondence[email protected]
,
Maria MalmVaccine Research Center, University of Tampere Medical School, Tampere, Finland
,
Daisuke ArinobuR&D Project Office, UMN Pharma Inc., Yokohama, Kanagawa, Japan
,
Suvi LappalainenVaccine Research Center, University of Tampere Medical School, Tampere, Finland
&
Timo VesikariVaccine Research Center, University of Tampere Medical School, Tampere, Finland
Pages 740-748 | Received 07 Jul 2015, Accepted 21 Sep 2015, Published online: 05 May 2016

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jordan E. Cates, Jacqueline E. Tate & Umesh Parashar. (2022) Rotavirus vaccines: progress and new developments. Expert Opinion on Biological Therapy 22:3, pages 423-432.
Read now
Lauren A. Ford-Siltz, Kentaro Tohma & Gabriel I. Parra. (2021) Understanding the relationship between norovirus diversity and immunity. Gut Microbes 13:1.
Read now
Jordan E. Cates, Jan Vinjé, Umesh Parashar & Aron J. Hall. (2020) Recent advances in human norovirus research and implications for candidate vaccines. Expert Review of Vaccines 19:6, pages 539-548.
Read now
Claire P. Mattison, Cristina V. Cardemil & Aron J. Hall. (2018) Progress on norovirus vaccine research: public health considerations and future directions. Expert Review of Vaccines 17:9, pages 773-784.
Read now

Articles from other publishers (26)

Matthias Schad, Saurabh Gautam, Tanja A. Grein & Friedrich Käß. 2023. Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs). Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs) 295 328 .
Annamalai RamaAnuja PaiDivya Rosa BarretoSiva Kumar KannanAnup Naha. (2022) Virus-Like particles as a Novel Targeted Drug Delivery Platform for Biomedical Applications. Research Journal of Pharmacy and Technology, pages 2801-2808.
Crossref
Zabihollah Shoja, Somayeh Jalilvand, Tayebeh Latifi & Farzin Roohvand. (2022) Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials. Archives of Virology 167:4, pages 1013-1023.
Crossref
Atefeh Afchangi, Somayeh Jalilvand, Arash Arashkia, Tayebeh Latifi, Mohammad Farahmand, Maryam Mashhadi Abolghasem Shirazi, Seyed Dawood Mousavi Nasab, Sayed Mahdi Marashi, Farzin Roohvand & Zabihollah Shoja. (2022) Co-administration of rotavirus nanospheres VP6 and NSP4 proteins enhanced the anti-NSP4 humoral responses in immunized mice. Microbial Pathogenesis 163, pages 105405.
Crossref
Sarah Caddy, Guido Papa, Alexander Borodavka & Ulrich Desselberger. (2021) Rotavirus research: 2014–2020. Virus Research 304, pages 198499.
Crossref
Timo Vesikari. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations 289 292 .
Kirsi Tamminen, Suvi Heinimäki, Stina Gröhn & Vesna Blazevic. (2020) Internalization and antigen presentation by mouse dendritic cells of rotavirus VP6 preparations differing in nanostructure. Molecular Immunology 123, pages 26-31.
Crossref
Kirsi Tamminen, Suvi Heinimäki, Timo Vesikari & Vesna Blazevic. (2020) Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo. Journal of Immunology Research 2020, pages 1-14.
Crossref
Kazuhiko KATAYAMA. (2020) Review Norovirusウイルス　ノロウイルス総説　2020. Uirusu 70:2, pages 117-128.
Crossref
Suvi Heinimäki, Minna M. Hankaniemi, Amir-Babak Sioofy-Khojine, Olli H. Laitinen, Heikki Hyöty, Vesa P. Hytönen, Timo Vesikari & Vesna Blazevic. (2019) Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus. Vaccine 37:51, pages 7509-7518.
Crossref
Rachel M. Burke, Jacqueline E. Tate, Carl D. Kirkwood, A. Duncan Steele & Umesh D. Parashar. (2019) Current and new rotavirus vaccines. Current Opinion in Infectious Diseases 32:5, pages 435-444.
Crossref
Maria Malm, André Diessner, Kirsi Tamminen, Markus Liebscher, Timo Vesikari & Vesna Blazevic. (2019) Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana. Pharmaceutics 11:5, pages 229.
Crossref
Atefeh Afchangi, Somayeh Jalilvand, Nasir Mohajel, Sayed Mahdi Marashi & Zabihollah Shoja. (2019) Rotavirus VP6 as a potential vaccine candidate. Reviews in Medical Virology 29:2, pages e2027.
Crossref
Nada M. Melhem, Farouk F. Abou Hassan & Mohammad Ramadan. 2019. Norovirus. Norovirus 189 242 .
Suvi Heinimäki, Maria Malm, Timo Vesikari & Vesna Blazevic. (2018) Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4 + T lymphocytes with cytotoxic potential. Antiviral Research 157, pages 1-8.
Crossref
Yalda Lucero, Roberto Vidal & Miguel O'Ryan G. (2018) Norovirus vaccines under development. Vaccine 36:36, pages 5435-5441.
Crossref
Atefeh AfchangiArash ArashkiaZahra ShahosseiniSomayeh JalilvandSayed Mahdi MarashiFarzin RoohvandNasir MohajelZabihollah Shoja. (2018) Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone. Viral Immunology 31:3, pages 233-241.
Crossref
Suvi Heinimäki, Kirsi Tamminen, Maria Malm, Timo Vesikari & Vesna Blazevic. (2017) Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigens. Virology 511, pages 114-122.
Crossref
Harish Changotra & Avni Vij. (2017) Rotavirus virus-like particles (RV-VLPs) vaccines: An update. Reviews in Medical Virology 27:6, pages e1954.
Crossref
Jones Anderson Monteiro Siqueira, Edivaldo Costa Sousa Júnior, Alexandre da Costa Linhares & Yvone Benchimol Gabbay. (2017) Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belém, Brazil: A community-based longitudinal study. Journal of Medical Virology 89:11, pages 1894-1903.
Crossref
Jones Anderson Monteiro Siqueira, Edivaldo Costa Sousa Júnior, Alexandre da Costa Linhares & Yvone Benchimol Gabbay. (2017) Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belém, Brazil: A community-based longitudinal study. Journal of Medical Virology 89:9, pages 1539-1549.
Crossref
M Malm, S Heinimäki, T Vesikari & V Blazevic. (2017) Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs. Clinical and Experimental Immunology 189:3, pages 331-341.
Crossref
Hao Feng, Xin Li, Weibin Song, Mei Duan, Hong Chen, Tao Wang & Jiangli Dong. (2017) Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice. Frontiers in Plant Science 8.
Crossref
Timo Vesikari. 2017. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations 247 249 .
Suvi Lappalainen, Timo Vesikari & Vesna Blazevic. (2016) Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins. Archives of Virology 161:11, pages 3219-3223.
Crossref
Maria Malm, Kirsi Tamminen, Suvi Lappalainen, Timo Vesikari & Vesna Blazevic. (2016) Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles. Journal of Immunology Research 2016, pages 1-13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.